Literature DB >> 12832281

SPRR1B overexpression enhances entry of cells into the G0 phase of the cell cycle.

Yohannes Tesfaigzi1, Paul S Wright, Steven A Belinsky.   

Abstract

Many studies have established the role of SPRR1B during squamous differentiation of skin and respiratory epithelial cells. However, its role in nonsquamous cells is largely unknown. We reported that expression of SPRR1B in Chinese hamster ovary (CHO) cells is increased as they enter the G0 phase of the cell cycle. The purpose of this study was to further investigate the SPRR1B expression pattern in nonsquamous tumors and to study its role in these cells. Expression of SPRR1B was detected by Northern blotting in a higher percentage of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced compared with beryllium metal-induced rat lung adenocarcinomas. In situ hybridizations confirmed that SPRR1B is expressed in individual or clusters of cells of nonsquamous cells from mouse, rat, and human adenocarcinomas. The same pattern of expression was observed in adenocarcinomas formed in nude mice from cell lines established from adenocarcinomas. SPRR1B expression was downregulated in the cell lines derived from adenocarcinoma when cells were enriched in G0 at low confluence. Tetraploidy was induced in CHO, mouse, and human tumor cell lines by stably overexpressing SPRR1B, whereas control cells showed no change in ploidy. Inducible expression of this protein for shorter periods using the ecdyson system did not affect growth rate or the ploidy of CHO cells but accelerated entry into G0/G1 compared with controls. These findings indicate that SPRR1B is likely coupled primarily to signals responsible for withdrawal from the proliferative state rather than the final stages of cellular quiescence and that its overexpression for prolonged periods may disrupt the normal progression of mitosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832281     DOI: 10.1152/ajplung.00065.2003

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  7 in total

1.  A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT.

Authors:  Shivaprasad Patil; Annett Linge; Hannah Hiepe; Marianne Grosser; Fabian Lohaus; Volker Gudziol; Max Kemper; Alexander Nowak; Dominik Haim; Inge Tinhofer; Volker Budach; Maja Guberina; Martin Stuschke; Panagiotis Balermpas; Jens von der Grün; Henning Schäfer; Anca-Ligia Grosu; Amir Abdollahi; Jürgen Debus; Ute Ganswindt; Claus Belka; Steffi Pigorsch; Stephanie E Combs; Simon Boeke; Daniel Zips; Korinna Jöhrens; Gustavo B Baretton; Michael Baumann; Mechthild Krause; Steffen Löck
Journal:  Cancers (Basel)       Date:  2022-06-20       Impact factor: 6.575

2.  A molecular signature of epithelial host defense: comparative gene expression analysis of cultured bronchial epithelial cells and keratinocytes.

Authors:  Joost B Vos; Nicole A Datson; Antoine H van Kampen; Angela C Luyf; Renate M Verhoosel; Patrick L Zeeuwen; Diana Olthuis; Klaus F Rabe; Joost Schalkwijk; Pieter S Hiemstra
Journal:  BMC Genomics       Date:  2006-01-18       Impact factor: 3.969

3.  MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma.

Authors:  Regina A Oyesanya; Shilpa Bhatia; Mitchell E Menezes; Catherine I Dumur; Karan P Singh; Sejong Bae; Dean A Troyer; Robert B Wells; Edward R Sauter; David Sidransky; Paul B Fisher; Oliver J Semmes; Santanu Dasgupta
Journal:  Oncoscience       Date:  2014-09-18

4.  Gene identification for risk of relapse in stage I lung adenocarcinoma patients: a combined methodology of gene expression profiling and computational gene network analysis.

Authors:  Vienna Ludovini; Fortunato Bianconi; Annamaria Siggillino; Danilo Piobbico; Jacopo Vannucci; Giulio Metro; Rita Chiari; Guido Bellezza; Francesco Puma; Maria Agnese Della Fazia; Giuseppe Servillo; Lucio Crinò
Journal:  Oncotarget       Date:  2016-05-24

5.  Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes.

Authors:  Dongbo Zhou; Mingxuan Xie; Baimei He; Ying Gao; Qiao Yu; Bixiu He; Qiong Chen
Journal:  Mol Med Rep       Date:  2017-08-14       Impact factor: 2.952

6.  Identification of small proline-rich protein 1B (SPRR1B) as a prognostically predictive biomarker for lung adenocarcinoma by integrative bioinformatic analysis.

Authors:  Zihe Zhang; Ruifeng Shi; Songlin Xu; Yongwen Li; Hongbing Zhang; Minghui Liu; Guangsheng Zhu; Chen Chen; Zhenhua Pan; Hongyu Liu; Jun Chen
Journal:  Thorac Cancer       Date:  2021-01-26       Impact factor: 3.500

7.  Hyperosmolality in CHO cell culture: effects on the proteome.

Authors:  Nadiya Romanova; Louise Schelletter; Raimund Hoffrogge; Thomas Noll
Journal:  Appl Microbiol Biotechnol       Date:  2022-03-21       Impact factor: 4.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.